Caen-Normandy University, France
Dr. Kave Moloudi is an internationally recognized scientist specializing in nanotheranostics, radiobiology, photodynamic therapy, and cancer nanomedicine. His academic and research activities focus on integrating nanotechnology with biomedical sciences to develop innovative therapeutic and diagnostic solutions for cancer treatment. Through extensive interdisciplinary collaborations, Dr. Moloudi has contributed to significant advancements in nanoparticle-based drug delivery systems, molecular imaging, radiotherapy enhancement, and tumor-targeted therapies. His strong publication profile, high citation count, and impactful scientific reviews demonstrate his growing influence within the global biomedical research community. He has collaborated with prominent researchers and institutions across multiple countries, strengthening international scientific partnerships and knowledge exchange. Dr. Moloudi’s work reflects originality, technical expertise, and dedication to improving translational cancer therapies through innovative biomedical technologies. His contributions to oncology and nanomedicine research continue to gain academic recognition, establishing him as a respected and promising researcher committed to advancing modern healthcare science and therapeutic innovation worldwide.
Professional Profile
Education
Dr. Kave Moloudi has developed a strong academic foundation in biomedical sciences, nanotechnology, radiobiology, and cancer therapy through advanced education and specialized scientific training. His educational journey reflects a deep commitment to interdisciplinary learning, combining principles of medicine, molecular biology, physics, and nanoscience to address complex healthcare challenges. Through academic research and technical coursework, he gained expertise in photodynamic therapy, nanoparticle engineering, imaging technologies, and therapeutic innovation. His educational background prepared him to conduct high-quality translational research and contribute to emerging areas of nanomedicine and oncology. Throughout his studies, Dr. Moloudi demonstrated analytical thinking, scientific curiosity, and dedication to advancing biomedical knowledge. His academic preparation also enabled him to collaborate effectively with international researchers and contribute to peer-reviewed scientific literature. The combination of theoretical knowledge and practical research experience has positioned him as a capable scientist actively supporting innovation in cancer treatment and modern biomedical technologies.
Professional Experience
Dr. Kave Moloudi possesses extensive research experience in nanomedicine, radiobiology, molecular imaging, and photodynamic cancer therapy. His professional activities involve interdisciplinary scientific investigations focused on improving therapeutic efficiency and advancing innovative biomedical applications. Through affiliations with international research institutions and universities, he has contributed to collaborative projects addressing cancer treatment strategies, nanoparticle-mediated therapies, and translational medicine. Dr. Moloudi has actively participated in experimental research, publication development, and scientific communication within the biomedical and oncology communities. His experience includes working alongside researchers from medical sciences, nanotechnology, and molecular medicine backgrounds, strengthening his multidisciplinary expertise. He has also contributed to reviews and investigations exploring therapeutic enhancement, tumor targeting, and advanced drug delivery systems. Through continuous involvement in scientific innovation and collaborative research environments, Dr. Moloudi has built a respected academic profile characterized by technical competence, research productivity, and dedication to improving healthcare technologies and biomedical treatment methodologies.
Research Interest
Dr. Kave Moloudi’s research interests focus on nanotheranostics, photodynamic therapy, cancer nanomedicine, radiobiology, molecular imaging, and advanced therapeutic technologies. His scientific investigations aim to improve cancer diagnosis and treatment using nanoparticle-based drug delivery systems, radiosensitizers, and innovative biomedical materials. He is particularly interested in enhancing the effectiveness of radiotherapy and photodynamic therapy while minimizing side effects associated with conventional cancer treatments. Dr. Moloudi also explores the biological interactions of nanoparticles, tumor microenvironment modulation, fluorescence imaging, and targeted therapeutic strategies for oncology applications. His work integrates nanotechnology, molecular medicine, and biomedical engineering to develop translational healthcare solutions with clinical relevance. Additionally, his research addresses immune modulation, apoptosis induction, and combination therapies designed to optimize treatment outcomes in cancer patients. Through interdisciplinary collaboration and innovative scientific approaches, Dr. Moloudi continues contributing to the advancement of personalized medicine, biomedical innovation, and next-generation cancer therapeutics.
Award and Honor
Dr. Kave Moloudi has gained substantial academic recognition through his influential research publications, strong citation record, and growing international scientific reputation in biomedical and nanomedicine research. His scholarly impact is demonstrated by a high h-index and numerous widely cited articles in respected journals related to oncology, nanotechnology, and molecular medicine. These achievements reflect the scientific community’s acknowledgment of his innovative contributions to cancer therapy and biomedical applications. His collaborations with internationally recognized researchers and institutions further highlight his professional credibility and research excellence. Dr. Moloudi’s work on photodynamic therapy, nanoparticle-based treatments, and radiobiology has attracted considerable academic attention and established him as a valuable contributor to modern healthcare research. Although formal public award listings may be limited, his publication achievements, citation influence, and interdisciplinary scientific advancements serve as indicators of distinction and professional accomplishment within the global biomedical and cancer research communities.
Conclusion
Dr. Kave Moloudi is a highly promising and accomplished researcher whose scientific contributions have significantly advanced nanomedicine, cancer therapy, radiobiology, and biomedical innovation. His interdisciplinary expertise, strong publication record, and international collaborations demonstrate a sustained commitment to improving modern healthcare research and therapeutic technologies. Through innovative investigations involving nanoparticles, molecular imaging, and photodynamic therapy, he has contributed valuable knowledge to oncology and translational medicine. His research impact, supported by impressive citation metrics and respected scientific publications, reflects both academic excellence and growing global recognition. Dr. Moloudi continues to strengthen his influence within the international biomedical research community through collaborative scientific efforts and consistent scholarly productivity. His dedication to advancing cancer treatment methodologies and improving patient-centered therapeutic approaches highlights his potential for future leadership in biomedical sciences. Overall, Dr. Moloudi represents a respected researcher with exceptional capability, innovation, and commitment to scientific advancement and healthcare improvement.
Publications Top Notes
Title: Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy
Authors: A. Narmani, R. Jahedi, E. Bakhshian-Dehkordi, S. Ganji, M. Nemati, et al.
Year: 2023
Citation: 96 Citations
Title: Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy
Authors: M. Keshavarz, K. Moloudi, R. Paydar, Z. Abed, J. Beik, H. Ghaznavi, et al.
Year: 2018
Citation: 88 Citations
Title: Resveratrol as an enhancer of apoptosis in cancer: a mechanistic review
Authors: M. Ashrafizadeh, S. Taeb, H. Haghi-Aminjan, S. Afrashi, K. Moloudi, et al.
Year: 2021
Citation: 70 Citations
Title: Modulation of the immune system by melatonin; implications for cancer therapy
Authors: M. Moslehi, R. Moazamiyanfar, M.S. Dakkali, S. Rezaei, N. Rastegar-Pouyani, et al.
Year: 2022
Citation: 57 Citations
Title: Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study
Authors: R. Abdollahzadeh, M.S. Fard, F. Rahmani, K. Moloudi, A. Azarnezhad
Year: 2016
Citation: 51 Citations